Search
for
Sort by
Research 301–330 of 1000+
- A randomized comparative study between intralesional vitamin D3 and intralesional triamcinolone acetonide in the treatment of alopecia areata
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Successful Treatment of Hair Loss and Restoration of Natural Hair Color in Patient with Alopecia Areata Due to Psychological Disorder Using Exosomes: Case Report with 6-Month Follow-Up
- Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Trichoscopy pattern in alopecia areata: A systematic review and meta‐analysis
- Alterations in Corneal Sensitivity, Staining and Biomechanics of Alopecia Areata Patients: Novel Findings in a Case-Control Study
- Retrospective Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Alopecia Areata in a Single Dermatological Department
- Beyond skin deep: Self-compassion mediates the link between body shame and psychopathology in people with alopecia and psoriasis
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Baricitinib: A Review in Severe Alopecia Areata
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis